Cargando…

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases

Detalles Bibliográficos
Autores principales:	Liu, Yuliang, Guo, Yingying, Li, Pengyong, Guo, Haipeng, Xu, Man
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588742/ https://www.ncbi.nlm.nih.gov/pubmed/37868779 http://dx.doi.org/10.3389/fcvm.2023.1296935

Ejemplares similares

Editorial: The Roles of Lipids in Immunometabolism: The Crosstalk Between Lipid Metabolisms and Inflammation
por: Zhang, Jue, et al.
Publicado: (2022)

Roles of Ferroptosis in Cardiovascular Diseases
por: Guo, Yuting, et al.
Publicado: (2022)

Current progress of ferroptosis in cardiovascular diseases
por: Zhang, Jie, et al.
Publicado: (2023)

The crosstalk among autophagy, apoptosis, and pyroptosis in cardiovascular disease
por: Cong, Lin, et al.
Publicado: (2022)

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021
por: Boucheniata, Chaymae, et al.
Publicado: (2022)

Editorial: Insights in lipids in cardiovascular disease: 2021
por: Levitan, Irena, et al.
Publicado: (2022)

Editorial: Mitochondria, metabolism and cardiovascular diseases
por: Koga, Jun-ichiro, et al.
Publicado: (2022)

Mapping current research and identifying hotspots of ferroptosis in cardiovascular diseases
por: Teng, Teng, et al.
Publicado: (2022)

The Link Between Ferroptosis and Cardiovascular Diseases: A Novel Target for Treatment
por: Hu, Huilin, et al.
Publicado: (2021)

Editorial: Intercellular communication and crosstalk in cardiac development and disease
por: Paik, David T., et al.
Publicado: (2022)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Research progress on the role of ferroptosis in cardiovascular disease
por: Li, Han, et al.
Publicado: (2022)

Ferroptosis: a new strategy for cardiovascular disease
por: Wang, Yuyuan, et al.
Publicado: (2023)

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

The Role of Ferroptosis in Cardiovascular Disease and Its Therapeutic Significance
por: Chen, Zhenzhen, et al.
Publicado: (2021)

The underlying pathological mechanism of ferroptosis in the development of cardiovascular disease
por: Zhang, Li-Li, et al.
Publicado: (2022)

Editorial: Metabolism Linking Immunity and Inflammatory Phenotypes in Cardiovascular Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Non-coding RNAs in necroptosis, pyroptosis, and ferroptosis in cardiovascular diseases
por: Cai, Yuxi, et al.
Publicado: (2022)

Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
por: Xiao, Xuan, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation in Cardiovascular Diseases
por: Pillai, Indulekha C. L., et al.
Publicado: (2022)

Editorial: Relationship Between Cardiovascular Disease and Other Chronic Conditions
por: Vassalle, Cristina, et al.
Publicado: (2022)

Non-fasting Changes in Blood Lipids After Three Daily Meals Within a Day in Chinese Inpatients With Cardiovascular Diseases
por: Tan, Yangrong, et al.
Publicado: (2022)

Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases
por: You, Mei, et al.
Publicado: (2023)

Editorial: Hypoxia in cardiovascular disease
por: Bilo, Grzegorz, et al.
Publicado: (2022)

Editorial: Autoimmunity and cardiovascular diseases
por: Khandker, Shahad Saif, et al.
Publicado: (2023)

Editorial: Cardiovascular imaging in the integrated assessment of metabolic health
por: Thomaides-Brears, Helena B., et al.
Publicado: (2023)

Editorial: Lipids and Inflammation in Health and Disease
por: Bezsonov, Evgeny, et al.
Publicado: (2022)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases
por: Liu, Chia-Feng, et al.
Publicado: (2023)

Editorial: Bio-materials for Cardiovascular Diseases
por: Campagnolo, Paola, et al.
Publicado: (2021)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

Editorial: Mitochondrial Dysfunction and Cardiovascular Diseases
por: Sadoshima, Junichi, et al.
Publicado: (2021)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

Editorial: Epigenetic regulation in cardiovascular diseases, volume II
por: Xu, Suowen, et al.
Publicado: (2023)

Editorial: Calcium Metabolism: Hormonal Crosstalk, Pathophysiology and Disease
por: Battafarano, Giulia, et al.
Publicado: (2022)

Editorial: The Non-coding Genome and Cardiovascular Disease
por: Mishra, Paras Kumar, et al.
Publicado: (2019)

Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease
por: Perticone, Maria, et al.
Publicado: (2022)

Editorial: Mitophagy and mitochondrial proteostasis in cardiovascular diseases
por: Dymkowska, Dorota, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkvhtm0jjnfkfjqs2goe2t341h